Cristiano Ronaldo has made an investment in a personalized supplement company that is focused on ensuring longevity.

Cristiano Ronaldo has made an investment in a personalized supplement company that is focused on ensuring longevity. Bioniq, a provider of

personalized supplements based on blood biomarker data and AI, has announced that CR7 has become a “significant shareholder.”Cristiano Ronaldo, the global soccer superstar, has elevated the practice of playing for additional time by investing a “substantial sum” in Bioniq, a British consumer health company. The company provides customized supplements that are developed by combining blood biomarker data with an AI-driven algorithm to enhance health and longevity. Ronaldo, a supplement user of the London-based company since 2022, will not only contribute to product innovation but also possess a stake in the company, according to Bioniq. Ronaldo’s strategic involvement is intended to leverage his experience as an elite athlete to assist in the development of the company’s future trajectory. He is recognized for his commitment to maintaining his health and performance throughout his distinguished career. Ronaldo stated in a statement, “My support for Bioniq is not merely an investment opportunity; it is a reflection of our shared vision for health, performance, and longevity.” “I have been personally utilizing their products for nearly three years.” I am of the opinion that Bioniq has the potential to revolutionize the way we care for our bodies and assist individuals in achieving and maintaining their optimal performance for an extended period of time through their personalized health approach. Bioniq’s personalized model denies the notion of a universal supplementation approach, instead utilizing data to customize nutrient support for each user. The company develops supplements that are entirely distinctive and are intended to assist users in optimizing their nutrient levels by utilizing a proprietary biochemical database that is derived from blood test data from users worldwide.

The optimal micronutrient blend for each individual is determined by the AI-powered platform of the company, which evaluates a variety of factors, including age, lifestyle, and health objectives. The supplement is custom-made for each user, thanks to the patented micro-dosing technique. This technique ensures that up to 120 distinct nutrients are delivered in prebiotic granules that are specifically designed to minimize nutrient competition and maximize assimilation in the body. Vadim Fedotov, the founder of Bioniq, emphasized the company’s commitment to longevity during our interview earlier this year. He stated, “We are assisting individuals in their efforts to enhance their well-being, which will enable their bodies to function more efficiently at a later stage of their lives and, I am convinced, will result in anti-aging.” Bioniq has been bolstering its global expansion, particularly in the United States, by forging partnerships with significant organizations such as Lanserhof and UFC. Currently, the United States accounts for over 60% of Bioniq’s global sales. The company claims that its customer base has expanded fivefold in 2024, and its supplements are now sold in over 70 countries. The primary user base is composed of athletes and individuals who are focused on longevity and performance. Ronaldo’s undisclosed investment, which follows a recent $15 million Series B funding round co-led by HV Capital and Unbound, has increased Bioniq’s total valuation to $82 million. David Kuczek, General Partner at HV Capital, stated, “Cristiano’s utilization of Bioniq to optimize his performance demonstrates that our product yields tangible outcomes.” “If it is effective for an elite athlete of his caliber, it is evident that it can be advantageous to ambitious consumers, assisting them in achieving their own health and performance objectives.”